Abstract
Abstract
Marine genetic resources hold great value for biotechnological innovation and sustainability-oriented research. However, studies indicate that intellectual property rights pertaining to these resources are concentrated in a handful of companies and countries, triggering contentious international debates. This paper highlights an overlooked dimension: scientists and their affiliated countries as central actors in the provision of marine genetic research. We introduce a dataset of 23,417 marine genetic studies and trace patent references to these studies. Our analysis reveals that molecular biological research, oftentimes on bacterial species, attracts the most patenting interest. Some countries own relatively more patents than they provide in science, with the U.S. benefiting the most from available research. Science by G77 researchers has seen limited uptake in patents. These findings aim to inform international biodiversity regimes, such as the UN treaty on Biodiversity Beyond National Jurisdiction (BBNJ), on how to more equitably distribute marine genetic resources’ economic, socio-cultural, and ecological benefits.
Publisher
Research Square Platform LLC
Reference73 articles.
1. The ocean genome and future prospects for conservation and equity;Blasiak R;Nat Sustain,2020
2. Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success;Martins A;Mar Drugs,2014
3. Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives;Tortorella E;Mar Drugs,2018
4. Degradation and metabolism of synthetic plastics and associated products by Pseudomonas sp.: capabilities and challenges;Wilkes RA;J Appl Microbiol,2017
5. Hurst, D., Børresen, T., Almesjö, L., Raedemaecker, F. & Bergseth, S. Marine Biotechnology Strategic Research and Innovation Roadmap - Insights to the future direction of European marine biotechnology. (Marine Biotechnology ERA-NET, 2016).